BGMSP
Bio Green Med Solution, Inc.
Key Financials
Operating Income
$-8427000
↑ 29.8%
Net Income
$-2998000
↑ 73.3%
Revenue
$0
↓ 100.0%
EPS (Diluted)
$-6.45
↓ 208.6%
Total Assets
$8.2M
↑ 99.9%
Total Liabilities
$1.3M
↓ 78.6%
Shareholders' Equity
$6.8M
↑ 414.7%
Cash & Equivalents
$3.5M
↑ 11.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/13/2026 | View on SEC |
| 10-K | 3/30/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| SCHEDULE 13G/A | 3/13/2026 | View on SEC |
| SCHEDULE 13G/A | 3/13/2026 | View on SEC |
| 8-K | 3/13/2026 | View on SEC |
| 8-K | 1/12/2026 | View on SEC |
| S-8 | 11/28/2025 | View on SEC |
| 10-K/A | 11/26/2025 | View on SEC |
| 4 | 11/13/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BGMSP |
| Company Name | Bio Green Med Solution, Inc. |
| CIK | 1130166 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 908-517-7330 |